Financials Natera, Inc.

Equities

NTRA

US6323071042

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
91.66 USD +0.42% Intraday chart for Natera, Inc. +7.48% +46.33%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,612 8,496 8,834 4,380 7,526 11,205 - -
Enterprise Value (EV) 1 2,295 8,011 8,250 3,843 6,997 10,793 10,701 10,446
P/E ratio -18.8 x -35 x -17.9 x -7.21 x -16.6 x -39.6 x -78.5 x -941 x
Yield - - - - - - - -
Capitalization / Revenue 8.64 x 21.7 x 14.1 x 5.34 x 6.95 x 8.36 x 7.06 x 6.03 x
EV / Revenue 7.59 x 20.5 x 13.2 x 4.69 x 6.46 x 8.06 x 6.74 x 5.62 x
EV / EBITDA -18.7 x -38.6 x -18.1 x -7.33 x -16.6 x -41.2 x -92.9 x 363 x
EV / FCF -33.5 x -39.6 x -21.4 x -8.02 x -24.5 x -95 x 299 x 55.5 x
FCF Yield -2.98% -2.52% -4.66% -12.5% -4.09% -1.05% 0.33% 1.8%
Price to Book 9.43 x 16.6 x 13.6 x 6.33 x 9.79 x 16.3 x 15.2 x 11.8 x
Nbr of stocks (in thousands) 77,529 85,370 94,595 109,033 120,152 122,242 - -
Reference price 2 33.69 99.52 93.39 40.17 62.64 91.66 91.66 91.66
Announcement Date 2/26/20 2/25/21 2/24/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 302.3 391 625.5 820.2 1,083 1,340 1,588 1,858
EBITDA 1 -122.9 -207.7 -456.9 -524.3 -422.1 -261.7 -115.2 28.76
EBIT 1 -130.7 -216.3 -468.2 -541 -446.2 -289.4 -149.8 -22.9
Operating Margin -43.22% -55.31% -74.85% -65.96% -41.22% -21.6% -9.43% -1.23%
Earnings before Tax (EBT) 1 -122.8 -229.6 -471.1 -546.8 -434.5 -280.2 -140.8 -0.9594
Net income 1 -124.8 -229.7 -471.7 -547.8 -434.8 -280.4 -141.8 -9.844
Net margin -41.29% -58.76% -75.42% -66.79% -40.16% -20.93% -8.93% -0.53%
EPS 2 -1.790 -2.840 -5.210 -5.570 -3.780 -2.316 -1.168 -0.0974
Free Cash Flow 1 -68.41 -202.1 -384.8 -479.2 -286.2 -113.7 35.8 188.1
FCF margin -22.63% -51.69% -61.52% -58.42% -26.43% -8.48% 2.25% 10.13%
FCF Conversion (EBITDA) - - - - - - - 654.07%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/26/20 2/25/21 2/24/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 158.1 173 194.1 198.2 210.6 217.3 241.8 261.4 268.3 311.1 315.7 328.1 339.1 356.3 373
EBITDA 1 -147.2 -136.7 -134.1 -138.5 -113.9 -137.8 -133.2 -107.3 -104 -77.62 -90.86 -75.32 -65.9 -54.34 -39.34
EBIT 1 -150.2 -139.7 -137.1 -143.1 -119.1 -141.8 -138.3 -112.4 -111 -84.54 -86.7 -77.69 -68.69 -56.82 -54.88
Operating Margin -94.99% -80.72% -70.64% -72.19% -56.52% -65.26% -57.21% -43.01% -41.36% -27.17% -27.46% -23.68% -20.26% -15.95% -14.72%
Earnings before Tax (EBT) 1 -151 -140.6 -138.4 -145 -121.3 -142.2 -136.8 -111.1 -108.8 -77.84 -86.57 -76.84 -66.97 -53.97 -52.51
Net income 1 -151.3 -140.6 -138.6 -145.2 -121.5 -142.6 -136.9 -110.8 -109 -78.03 -86.03 -75.6 -65.86 -53.81 -52.57
Net margin -95.67% -81.24% -71.39% -73.23% -57.67% -65.63% -56.64% -42.39% -40.64% -25.08% -27.26% -23.05% -19.42% -15.1% -14.1%
EPS 2 -1.630 -1.490 -1.450 -1.500 -1.250 -1.370 -1.230 -0.9700 -0.9500 -0.6400 -0.7183 -0.6294 -0.5483 -0.4432 -0.4181
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/24/22 5/5/22 8/4/22 11/8/22 2/28/23 5/9/23 8/3/23 11/8/23 2/28/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 317 485 584 536 529 412 503 758
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -68.4 -202 -385 -479 -286 -114 35.8 188
ROE (net income / shareholders' equity) -89.6% -60.1% -82.8% -80.6% -59.1% -39.2% -13.8% 3.23%
ROA (Net income/ Total Assets) -32.7% -30.3% -43.5% -41.6% -30.7% -21.4% -8.6% -1.1%
Assets 1 381.4 757.4 1,084 1,315 1,418 1,313 1,650 894.9
Book Value Per Share 2 3.570 6.000 6.870 6.340 6.400 5.640 6.050 7.760
Cash Flow per Share 2 -0.9100 -2.250 -3.700 -4.380 -2.150 -0.2600 0.6300 2.200
Capex 1 4.97 19.6 49.6 47.7 39.2 42.6 51.5 57.9
Capex / Sales 1.64% 5.01% 7.93% 5.82% 3.62% 3.18% 3.24% 3.12%
Announcement Date 2/26/20 2/25/21 2/24/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
91.66 USD
Average target price
103.1 USD
Spread / Average Target
+12.50%
Consensus
  1. Stock Market
  2. Equities
  3. NTRA Stock
  4. Financials Natera, Inc.